For example, reduced expression of Notch targets, namely HES1, HEY1, and especially HEY2, was seen in clinically progressed oligodendroglioma, while HES5 expression was most associated with shorter survival on multivariable analysis. The gene discussed is HES1; the disease is oligodendroglioma.